PROFUND ADVISORS LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$414,126
-39.3%
130,639
-4.8%
0.02%
-37.8%
Q2 2023$682,043
+10.8%
137,232
+10.1%
0.04%
-2.6%
Q1 2023$615,578
+426.1%
124,611
+1118.2%
0.04%
+442.9%
Q2 2022$117,000
+14.7%
10,229
-9.0%
0.01%
+75.0%
Q1 2022$102,000
-45.2%
11,243
-10.0%
0.00%
-33.3%
Q4 2021$186,000
-48.2%
12,492
-10.6%
0.01%
-50.0%
Q3 2021$359,000
+3.2%
13,980
+4.7%
0.01%0.0%
Q2 2021$348,000
-25.8%
13,349
+0.4%
0.01%
-33.3%
Q1 2021$469,000
+27.4%
13,294
-8.9%
0.02%
+12.5%
Q4 2020$368,000
-25.7%
14,586
+11.1%
0.02%
-36.0%
Q3 2020$495,000
-23.4%
13,132
-12.9%
0.02%
-30.6%
Q2 2020$646,000
+224.6%
15,078
+47.7%
0.04%
+140.0%
Q1 2020$199,000
-46.5%
10,211
-28.6%
0.02%
-6.2%
Q4 2019$372,000
+8.5%
14,300
+13.6%
0.02%
-5.9%
Q3 2019$343,00012,5880.02%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders